中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

Influence of metabolic syndrome on patients with recurrence of hypertriglyceridemic acute pancreatitis

DOI: 10.3969/j.issn.1001-5256.2020.11.023
  • Received Date: 2020-04-15
  • Published Date: 2020-11-20
  • Objective To investigate the features of patients with recurrence of hypertriglyceridemic acute pancreatitis( HTG-AP) and the influence of metabolic syndrome( MetS) on recurrence through a retrospective analysis. Methods A retrospective analysis was performed for 132 patients with recurrent HTG-AP who were admitted to The Affiliated Hospital of Southwest Medical University from June 2013 to December( recurrence group),and 132 patients with non-recurrent HTG-AP who were treated during the same period of time were enrolled as control group. Related data were collected,including basic information( age,sex,diabetes,hypertension,and body mass index),clinical data( etiology,routine blood test results,and biochemical results),and complications [systemic inflammatory response syndrome( SIRS),acute peripancreatic fluid collection( APFC),acute necrosis collection( ANC),acute respiratory distress syndrome( ARDS),acute renal failure( ARF),multiple organ dysfunction syndrome( MODS),and ICU admission rate]. The t-test was used for comparison of normally distributed continuous data between groups,and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between groups; the chi-square test or the Fisher's exact test was used for comparison of categorical data between groups.A logistic regression analysis was used for comparison of related variables,and the receiver operating characteristic( ROC) curve was used to validate the diagnostic value of variables. Results Compared with the control group,the recurrence group had a significantly higher proportion of patients with MetS,obesity,a high-density lipoprotein cholesterol( HDL-C) level of < 1 mmol/L,or ANC and significantly higher levels of blood glucose and C-reactive protein( CRP) and white blood cell count( WBC)( χ2= 9. 138,χ2= 6. 823,χ2= 13. 251,χ2=9. 587,Z =-2. 255,Z =-2. 202,Z =-4. 674,all P < 0. 05). The 132 patients in the recurrence group were divided into MetS group with 92 patients and non-Met S group with 40 patients,and compared with the non-Met S group,the Met S group had significantly higher WBC and blood glucose and a significantly higher proportion of patients with SIRS,APFC,ANC,or progression to moderate-to-severe AP( MSAP)( t = 2. 434,t = 4. 881,χ2= 4. 513,χ2= 7. 936,χ2= 7. 031,χ2= 7. 150,all P < 0. 05). Met S( odds ratio [OR]= 2. 007,95%confidence interval [CI]: 1. 152-3. 497,P < 0. 05),ANC( OR = 2. 270,95% CI: 1. 185-4. 347,P < 0. 05),and WBC( OR = 1. 135,95% CI: 1. 059-1. 217,P < 0. 05) were independent risk factors for recurrence in HTG-AP patients. The combination of Met S,ANC,and WBC had a relatively high value in predicting the recurrence of HTG-AP,with an area under the ROC curve of 0. 692. In the recurrence group,the levels of triglyceride,blood glucose,and CRP and the proportion of patients with smoking,HDL-C < 1 mmol/L,or obesity in 125 patients( 7 patients were excluded due to incomplete case data) at the time of recurrence were significantly lower than those in 132 patients at initial admission( Z =-3. 270,Z =-3. 546,Z =-4. 382,χ2= 0547,χ2= 8. 259,χ2= 5. 143,all P < 0. 05),with further reductions in the proportion of patients with MSAP,APFC,or ANC( χ2= 4. 086,χ2= 11. 930,χ2= 4. 967,all P < 0. 05).Conclusion Met S aggravates disease severity in patients with recurrent HTG-AP and is an important factor for recurrence. Smoking cessation,weight loss,and oral lipid-lowering drugs can reduce disease severity at the time of readmission.

     

  • [1] Pancreas Study Group,Chinese Society of Gastroenterology,Chinese Medical Association; Editorial Board of Chinese Journal of Pancreatology,Editorial Board of Chinese Journal of Digestion. Chinese guidelines for the management of acute pancreatitis(Shenyang,2019)[J]. J Clin Hepatol,2019,35(12):2706-2711.(in Chinese)中华医学会消化病学分会胰腺疾病学组,《中华胰腺病杂志》编委会,《中华消化杂志》编委会.中国急性胰腺炎诊治指南(2019年,沈阳)[J].临床肝胆病杂志,2019,35(12):2706-2711.
    [2] FORSMARK CE,VEGE SS,WILCOX CM. Acute pancreatitis[J]. N Engl J Med,2016,375(20):1972-1981.
    [3] GARG SK,SARVEPALLI S,CAMPBELL JP,et al. Incidence,admission rates,and predictors,and economic burden of adult emergency visits for acute pancreatitis:Data from the national emergency department sample,2006 to 2012[J]. J Clin Gastroenterol,2019,53(3):220-225.
    [4] ZHOU MT,SHI KQ,TIAN X,et al. Clinical classification and treatment of hyperlipidemic acute pancreatitis[J]. J Hepatopancreatobiliary Surg,2019,31(1):19-20.(in Chinese)周蒙滔,施可庆,田新,等.高脂血症性急性胰腺炎的临床分型及救治方案[J].肝胆胰外科杂志,2019,31(1):19-20.
    [5] SEPPANEN H,PUOLAKKAINEN P. Classification,severity assessment,and prevention of recurrences in acute pancreatitis[J]. Scand J Surg,2020,109(1):53-58.
    [6] CHO JH,JEONG YH,KIM KH,et al. Risk factors of recurrent pancreatitis after first acute pancreatitis attack:A retrospective cohort study[J]. Scand J Gastroenterol,2020,55(1):90-94.
    [7] MIKOLASEVIC I,MILIC S,ORLIC L,et al. Metabolic syndrome and acute pancreatitis[J]. Eur J Intern Med,2016,32:79-83.
    [8] DOUBILET H,MULHOLLAND JH. Recurrent acute pancreatitis,observations on etiology and surgical treatment[J]. Ann Surg,1948,128(4):609-638.
    [9] ZHANG FS,MA HY,ZOU DP. Analysis of clinical features and causes of acute recurrent pancreatitis[J]. Mod Med J China,2019,21(8):81-83.(in Chinese)张佛生,马海云,邹大朋.急性复发性胰腺炎的临床特点和病因分析[J].中国现代医药杂志,2019,21(8):81-83.
    [10] AHMED ALI U,ISSA Y,HAGENAARS JC,et al. Risk of recurrent pancreatitis and progression to chronic pancreatitis after a first episode of acute pancreatitis[J]. Clin Gastroenterol Hepatol,2016,14(5):738-746.
    [11] MAGNUSDOTTIR BA,BALDURSDOTTIR MB,KALAITZAKIS E,et al. Risk factors for chronic and recurrent pancreatitis after first attack of acute pancreatitis[J]. Scand J Gastroenterol,2019,54(1):87-94.
    [12] XIANG JX,HU LS,LIU P,et al. Impact of cigarette smoking on recurrence of hyperlipidemic acute pancreatitis[J]. World J Gastroenterol,2017,23(47):8387-8394.
    [13] PANG Y,KARTSONAKI C,TURNBULL I,et al. Metabolic and lifestyle risk factors for acute pancreatitis in Chinese adults:A prospective cohort study of 0. 5 million people[J]. PLo S Med,2018,15(8):e1002618.
    [14] McCRACKEN E,MONAGHAN M,SREENIVASAN S. Pathophysiology of the metabolic syndrome[J]. Clin Dermatol,2018,36(1):14-20.
    [15] LI X,GUO X,JI H,et al. Relationships between metabolic comorbidities and occurrence,severity,and outcomes in patients with acute pancreatitis:A narrative review[J]. Biomed Res Int,2019,2019:2645926.
    [16] SZENTESI A,PARNICZKY A,VINCZEA,et al. Multiple hits in acute pancreatitis:Components of metabolic syndrome synergize each other’s deteriorating effects[J]. Front Physiol,2019,10:1202.
    [17] HUANG Y,WANG Y. Clinical analysis of diabetes mel itus complicated with hyperlipidemic acute pancreatitis[J]. Chin J Gastroenterol,2018,23(7):423-425.(in Chinese)黄瑶,王营.糖尿病合并高脂血症性急性胰腺炎的临床分析[J].胃肠病学,2018,23(7):423-425.
    [18] NIU L,GE LC. Acute recurrent pancreatitis and hyperlipidemia:Reciprocal causal relationship and clinical features[J]. World Chin J Dig,2016,24(30):4205-4210.(in Chinese)牛蕾,葛林春.急性复发性胰腺炎与高脂血症的互为因果关系及临床特点[J].世界华人消化杂志,2016,24(30):4205-4210.
    [19] NIKNAM R,MORADI J,JAHANSHAHI KA,et al. Association between metabolic syndrome and its components with severity of acute pancreatitis[J]. Diabetes Metab Syndr Obes,2020,13:1289-1296.
    [20] KISS L,FUR G,MATRAI P,et al. The effect of serum triglyceride concentration on the outcome of acute pancreatitis:systematic review and meta-analysis[J]. Sci Rep,2018,8(1):14096.
    [21] MIKOA,FARKAS N,GARAMI A,et al. Preexisting diabetes elevates risk of local and systemic complications in acute pancreatitis:Systematic review and meta-analysis[J]. Pancreas,2018,47(8):917-923.
    [22] CATANZARO R,CUFFARI B,ITALIA A,et al. Exploring the metabolic syndrome:Nonalcoholic fatty pancreas disease[J]. World J Gastroenterol,2016,22(34):7660-7675.
    [23] ALEMPIJEVIC T,DRAGASEVIC S,ZEC S,et al. Non-alcoholic fatty pancreas disease[J]. Postgrad Med J,2017,93(1098):226-230.
    [24] PATEL K,TRIVEDI RN,DURGAMPUDI C,et al. Lipolysis of visceral adipocyte triglyceride by pancreatic lipases converts mild acute pancreatitis to severe pancreatitis independent of necrosis and inflammation[J]. Am J Pathol,2015,185(3):808-819.
    [25] JIANG XL,YANG F,WANG CH,et al. Correlation between serum level of cytokine and disease severity in HALP patients[J]. Med J West China,2017,29(4):489-493,498.(in Chinese)蒋晓岚,杨帆,王春晖,等.高脂血症性急性胰腺炎血清细胞因子水平与病情严重程度的相关性[J].西部医学,2017,29(4):489-493,498.
    [26] BAIG S,SHABEER M,PARVARESH RIZI E,et al. Heredity of type 2 diabetes confers increased susceptibility to oxidative stress and inflammation[J]. BMJ Open Diabetes Res Care,2020,8(1):e000945.
    [27] KEBKALO A,TKACHUK O,REYTI A. Features of the course of acute pancreatitis in patients with obesity[J]. Pol Przegl Chir,2019,91(6):28-34.
    [28] SHARMA D,JAKKAMPUDI A,REDDY R,et al. Association of systemic inflammatory and anti-inflammatory responses with adverse outcomes in acute pancreatitis:Preliminary results of an ongoing study[J]. Dig Dis Sci,2017,62(12):3468-3478.
    [29] RUIZ-REBOLLO ML,MUNOZ-MORENO MF,MAYOISCAR A,et al. Statin intake can decrease acute pancreatitis severit[J]. Pancreatology,2019,19(6):807-812.
  • Relative Articles

    [1]Meng LU, Mingjie WANG, Li CHEN. Advances in the application of elastography in noninvasive diagnosis of liver fibrosis in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2023, 39(2): 408-412. doi: 10.3969/j.issn.1001-5256.2023.02.025
    [2]Zhiran YANG, Linheng WANG, Yuan LI, Fusheng LIU, Yu WANG, Jianfang WANG, Runhua CHEN. Diagnostic value of transient elastography in the staging of hepatic fibrosis in patients with autoimmune liver disease: A Meta-analysis[J]. Journal of Clinical Hepatology, 2022, 38(1): 97-103. doi: 10.3969/j.issn.1001-5256.2022.01.015
    [3]Mingjie YAO, Xiajie WEN, Leijie WANG, Qiong HE, Jianwen LUO, Jiangao FAN, Qing XIE, Chengwei CHEN, Qing Chun FU, Jun Ping SHI, Yongfeng YANG, Yun XU, Lungen LU, Fengmin LU. Establishment of a model for evaluating the severity of nonalcoholic fatty liver disease based on transient elastography parameters[J]. Journal of Clinical Hepatology, 2021, 37(7): 1614-1618. doi: 10.3969/j.issn.1001-5256.2021.07.027
    [4]Kaimin SONG, Jun LIU. Advances in the application of transient elastography in chronic hepatitis B[J]. Journal of Clinical Hepatology, 2021, 37(2): 419-424. doi: 10.3969/j.issn.1001-5256.2021.02.036
    [5]Lin JingQi, Tian Bing, Deng BaoCheng. Application of ultrasound elastography in evaluating portal hypertension[J]. Journal of Clinical Hepatology, 2020, 36(10): 2310-2314. doi: 10.3969/j.issn.1001-5256.2020.10.033
    [6]Chen WeiTing, Li ShuangJie. Clinical value of transient elastography,aspartate aminotransferase-to-platelet ratio index,and fibrosis-4 in the diagnosis of liver fibrosis in children with biliary atresia[J]. Journal of Clinical Hepatology, 2020, 36(3): 546-550. doi: 10.3969/j.issn.1001-5256.2020.03.015
    [7]SUN YiFei, HUANG LiPing. Noninvasive evaluation of esophageal and gastric varices in liver cirrhosis by shear-wave ultrasound elastography[J]. Journal of Clinical Hepatology, 2020, 36(12): 2815-2818. doi: 10.3969/j.issn.1001-5256.2020.12.036
    [8]Zhang DaKun, Chen Min, Zhang WenHui, Wang RuiFang, Shi XiaoJuan. Clinical value of acoustic radiation force impulse elastography in predicting esophageal variceal bleeding in liver cirrhosis[J]. Journal of Clinical Hepatology, 2020, 36(3): 561-564. doi: 10.3969/j.issn.1001-5256.2020.03.018
    [9]Liu LinXiang, Nie Yuan, Zhu Xuan. Clinical application of transient elastography in liver cirrhosis and its complications[J]. Journal of Clinical Hepatology, 2020, 36(6): 1362-1365. doi: 10.3969/j.issn.1001-5256.2020.06.037
    [10]Luo WenPing, Ma Hong, Wang Yu. Advances in the application of transient elastography in noninvasive diagnosis of liver fibrosis[J]. Journal of Clinical Hepatology, 2019, 35(3): 635-639. doi: 10.3969/j.issn.1001-5256.2019.03.041
    [11]Chen Min, Zhang DaKun, Gao YueJuan, Li Meng, Wang RuiFang, Zhang WenHui. Clinical value of acoustic radiation force impulse in quantitative prediction of the degree of esophageal varices in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2018, 34(1): 80-83. doi: 10.3969/j.issn.1001-5256.2018.01.016
    [12]Xu FengMing, Sheng QingShou. Research advances in serum markers and transient elastography in the evaluation of liver fibrosis[J]. Journal of Clinical Hepatology, 2018, 34(3): 618-622. doi: 10.3969/j.issn.1001-5256.2018.03.040
    [13]Dong Xue, Huang LiPing. Research advances in the value of ultrasound elastography in the diagnosis of gastroesophageal varices in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2018, 34(11): 2424-2427. doi: 10.3969/j.issn.1001-5256.2018.11.035
    [14]Wu Yue, Huang LiPing. Value of real-time shear wave elastography in evaluating classification of liver fibrosis: a Meta-analysis[J]. Journal of Clinical Hepatology, 2017, 33(9): 1717-1721. doi: 10.3969/j.issn.1001-5256.2017.09.017
    [15]Zhuang XiaoFang, Sun Jie, Wang XiaoBo, Wang Yan, Wu QiQi, Wang XiaoZhong. Performance of transient elastography in diagnosis of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(12): 2366-2371. doi: 10.3969/j.issn.1001-5256.2017.12.022
    [16]Zhang XiaoTong, Guo LiPing. Value of ultrasonic elastography in diagnosis of liver diseases[J]. Journal of Clinical Hepatology, 2016, 32(11): 2210-2213. doi: 10.3969/j.issn.1001-5256.2016.11.048
    [17]Yang MingLei, Yao DingKang. Application of magnetic resonance elastography as a non-invasive technique for diagnosis of liver fibrosis[J]. Journal of Clinical Hepatology, 2016, 32(3): 588-592. doi: 10.3969/j.issn.1001-5256.2016.03.042
    [18]Zhou JiaLing, Wei Wei, You Hong. Progress in clinical studies of noninvasive early diagnosis of liver fibrosis and cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(7): 604-607. doi: 10.3969/j.issn.1001-5256.2014.07.007
    [19]Zhang GuoSheng, Wang TianYi, Xu YouQing, Zhou Li, Geng Nan, Chen Yu. Diagnostic value of real-time tissue elastography for liver fibrosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2014, 30(7): 616-619. doi: 10.3969/j.issn.1001-5256.2014.07.010
    [20]Mai Jing, Gao YueQiu. The application of magnetic resonace elastography in the non-invasive diagnosis of hepatic fibrosis[J]. Journal of Clinical Hepatology, 2011, 27(3): 318-320+324.
  • Cited by

    Periodical cited type(12)

    1. 朱成诚,丁世兰. 超声剪切波弹性成像对肝纤维化的临床应用进展. 现代医药卫生. 2022(22): 3874-3879+3883 .
    2. 肖毅,秦建伟. 肝硬化患者门静脉压力、脾静脉血流参数与SWE结果的特征分析. 甘肃科技. 2020(12): 101-104 .
    3. 董丙田,黄枢. 超声弹性成像在肝脏疾病的临床应用. 医学综述. 2019(05): 1002-1006 .
    4. 刘旭. 门静脉右支前间隙行磁共振改良测量对肝纤维化和肝硬化的诊断效果. 肝脏. 2019(05): 541-544 .
    5. 杨淑丽,诸绍锋,张蕾,石鹏,王姜莹,傅佳. 超声实时组织弹性成像定量分析对肝脏纤维化程度的诊断和鉴别诊断价值. 中国临床保健杂志. 2019(04): 526-529 .
    6. 林培艺. 无创性肝纤维化检测对肝硬化严重程度的评估作用. 慢性病学杂志. 2019(07): 1109-1110+1113 .
    7. 秦敏. 术前瞬时弹性超声检查对肝内结石肝切除术安全性的影响. 肝脏. 2019(08): 935-938 .
    8. 许琴,贡雪灏,郭国强. 实时剪切波弹性成像对慢性乙型肝炎患者早期肝纤维化的诊断价值. 临床和实验医学杂志. 2019(20): 2225-2227 .
    9. 孟艳,隆仙琴,李杰,丁文波. RTE与VTI对肝脏局灶良恶性病变的诊断. 中国临床研究. 2018(02): 255-258 .
    10. 杨皖东,肖春华,陈晓,普慧敏. 弹性成像技术对肝移植供体评估的研究进展. 中国当代医药. 2018(03): 18-20 .
    11. 徐列明. 中医药抗肝纤维化疗效评价的探索. 临床肝胆病杂志. 2017(05): 825-828 . 本站查看
    12. 梁健,钟碧莹,汤茵,肖秀金,叶红. 肝纤维化检测在非酒精性脂肪肝诊断中的应用研究. 中国卫生标准管理. 2017(17): 110-113 .

    Other cited types(6)

  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-040510152025
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 2.3 %FULLTEXT: 2.3 %META: 88.5 %META: 88.5 %PDF: 9.2 %PDF: 9.2 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 4.4 %其他: 4.4 %China: 0.5 %China: 0.5 %India: 0.5 %India: 0.5 %上海: 1.4 %上海: 1.4 %丽水: 0.2 %丽水: 0.2 %北京: 11.0 %北京: 11.0 %南京: 0.2 %南京: 0.2 %南宁: 0.2 %南宁: 0.2 %台州: 1.6 %台州: 1.6 %吉林: 0.9 %吉林: 0.9 %哥伦布: 0.5 %哥伦布: 0.5 %张家口: 7.9 %张家口: 7.9 %无锡: 0.2 %无锡: 0.2 %杭州: 0.9 %杭州: 0.9 %泰安: 0.2 %泰安: 0.2 %洛阳: 0.2 %洛阳: 0.2 %深圳: 0.2 %深圳: 0.2 %湖州: 2.6 %湖州: 2.6 %美国伊利诺斯芝加哥: 0.2 %美国伊利诺斯芝加哥: 0.2 %芒廷维尤: 22.7 %芒廷维尤: 22.7 %莆田: 0.5 %莆田: 0.5 %莫斯科: 1.6 %莫斯科: 1.6 %衢州: 2.3 %衢州: 2.3 %西宁: 35.7 %西宁: 35.7 %遵义: 0.5 %遵义: 0.5 %重庆: 0.2 %重庆: 0.2 %金华: 0.2 %金华: 0.2 %长春: 1.6 %长春: 1.6 %随州: 0.2 %随州: 0.2 %马鞍山: 0.2 %马鞍山: 0.2 %其他ChinaIndia上海丽水北京南京南宁台州吉林哥伦布张家口无锡杭州泰安洛阳深圳湖州美国伊利诺斯芝加哥芒廷维尤莆田莫斯科衢州西宁遵义重庆金华长春随州马鞍山

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (4503) PDF downloads(96) Cited by(18)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return